AXXERIUM EQUITY CAPITALS CORP.
Institutional Landing Page
Strategic Investment Partner – Republic of Panama
Socio de Inversión Estratégica – República de Panamá
Exclusive Institutional Placement Vehicle 10% Strategic Equity Participation in OGRD Alliance Biotech L.L.C-FZ (Meydan Free Zone, Dubai)
Investment Snapshot
Investment Opportunity
AXXERIUM EQUITY CAPITALS CORP. acts as a dedicated Special Purpose Vehicle (SPV) and exclusive Strategic Investment Partner for the institutional placement of a 10 % equity participation in OGRD Alliance Biotech L.L.C-FZ.
The offering is conducted exclusively through regulated crowdfunding portals and is available only to accredited and sophisticated investors following full KYC/AML verification.
This clean, asset-light NewCo domiciled in the Meydan Free Zone serves as the custodian of the complete PLPC™ Platform — a fully de-risked biomedical ecosystem centered on high-value intellectual property, regulatory-ready dossiers and audited real-world evidence.
Investors receive pure exposure to the intellectual property without assuming operational manufacturing risk or cash-burn exposure.
All investor funds flow directly and exclusively to the Holding Company (OGRD Alliance LLC-FZ) under strict Board oversight, transparent governance, global legal counsel and independent financial advisory.
Intellectual Capital & Development Legacy
The platform has been developed over more than 12 years of continuous scientific and technical investment, resulting in:
- 581 protected intellectual property assets with clear chain of title
- Over 1,500 proprietary classified documents organized across 19 thematic categories
- Audited real-world evidence from 3,572 patients with zero serious adverse events
- NAM-aligned regulatory dossiers ready for accelerated recognition
This intellectual capital forms a robust competitive moat and supports milestone-driven value creation in Latin American and selected international markets.
The PLPC™ Platform – Three Synergistic Pillars
Eliminates cellular manufacturing complexity.
Near-term revenue with lower regulatory hurdles.
Accelerates global regulatory and commercial scalability.
Market Context & Value Creation Precedents
Biotechnology platforms with strong intellectual property portfolios and de-risked real-world evidence have historically demonstrated consistent patterns of institutional value creation in free-zone jurisdictions, particularly through:
- Regulatory milestone-driven re-rating
- Superior capital efficiency in asset-light structures
- Professional governance and transparent funds flow
AXXERIUM's mandate follows these established market patterns, providing investors with a structured, transparent and professionally governed opportunity.
Why Institutional Investors Choose AXXERIUM
- Dedicated SPV structure designed specifically for institutional-grade equity placement
- Pure exposure to a high-value intellectual property portfolio
- Fully transparent direct-to-Holding funds flow with Board-level oversight
- Professional Panamanian corporate vehicle with international reach
- Global legal and financial advisory framework
- Strict compliance with KYC/AML and accredited-investor requirements
- Clear regulatory roadmap and near-term commercialization potential
Ready to Proceed?
Access the Full Institutional Investor Package (Private Placement Memorandum • Legal Opinion Letters • Financial Opinion Letter • Complete Data Room)
Request Accredited Investor Access